DE69226192D1 - Sparfloxacin-Salze und sie enthaltende Lösungen - Google Patents

Sparfloxacin-Salze und sie enthaltende Lösungen

Info

Publication number
DE69226192D1
DE69226192D1 DE69226192T DE69226192T DE69226192D1 DE 69226192 D1 DE69226192 D1 DE 69226192D1 DE 69226192 T DE69226192 T DE 69226192T DE 69226192 T DE69226192 T DE 69226192T DE 69226192 D1 DE69226192 D1 DE 69226192D1
Authority
DE
Germany
Prior art keywords
sparfloxacin
salts
monocarboxylic
pharmaceutically acceptable
solutions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69226192T
Other languages
English (en)
Inventor
Guillaume Conrath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone DPC Europe
Original Assignee
Rhone DPC Europe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone DPC Europe filed Critical Rhone DPC Europe
Application granted granted Critical
Publication of DE69226192D1 publication Critical patent/DE69226192D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
DE69226192T 1991-09-27 1992-09-25 Sparfloxacin-Salze und sie enthaltende Lösungen Expired - Lifetime DE69226192D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9111913A FR2681863B1 (fr) 1991-09-27 1991-09-27 Solution de sparfloxacine sa preparation et sel la constituant.
PCT/FR1992/000891 WO1993005782A1 (fr) 1991-09-27 1992-09-25 Sels de sparfloxacine et solutions les contenant

Publications (1)

Publication Number Publication Date
DE69226192D1 true DE69226192D1 (de) 1998-08-13

Family

ID=9417358

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69226192T Expired - Lifetime DE69226192D1 (de) 1991-09-27 1992-09-25 Sparfloxacin-Salze und sie enthaltende Lösungen

Country Status (22)

Country Link
US (1) US5478829A (de)
EP (2) EP0534860A1 (de)
JP (1) JPH07503941A (de)
AT (1) ATE168008T1 (de)
AU (1) AU671602B2 (de)
CA (1) CA2119270A1 (de)
CZ (1) CZ69494A3 (de)
DE (1) DE69226192D1 (de)
FI (1) FI941399A0 (de)
FR (1) FR2681863B1 (de)
HU (1) HUT67672A (de)
IL (1) IL103270A (de)
MX (1) MX9205461A (de)
NO (1) NO941036L (de)
NZ (1) NZ244479A (de)
PL (2) PL170495B1 (de)
SG (1) SG59982A1 (de)
SK (1) SK34894A3 (de)
TW (1) TW202393B (de)
WO (1) WO1993005782A1 (de)
YU (1) YU86792A (de)
ZA (1) ZA927330B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5103898A (en) * 1996-11-05 1998-05-29 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
EP1685843A1 (de) * 1999-06-30 2006-08-02 Ruey J. Dr. Yu Oligosaccharidealdonsäure und ihre topische Verabreichung
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
US6335023B1 (en) 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
DE19937115A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE19962353A1 (de) 1999-12-23 2001-07-05 Henkel Ecolab Gmbh & Co Ohg Hepatitis A Viruzid
US6979471B1 (en) * 2000-09-05 2005-12-27 Council Of Scientific And Industrial Research Composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from Glycyrrhiza glabra
WO2003015752A1 (en) * 2001-08-14 2003-02-27 Bakulesh Mafatlal Khamar The process for preparing isotonic topical antibiotic ophthalmic formulation with improved therapeutic effect
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
TW200900066A (en) * 2007-03-22 2009-01-01 Daiichi Sankyo Co Ltd Quinolone medical composition containing alcohols
EP2712611A1 (de) * 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilisierte wässrige Zusammensetzungen von neuromuskulären Blockiermitteln

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤

Also Published As

Publication number Publication date
NO941036D0 (no) 1994-03-22
EP0605646B1 (de) 1998-07-08
HU9400868D0 (en) 1994-06-28
US5478829A (en) 1995-12-26
FI941399A (fi) 1994-03-25
FI941399A0 (fi) 1994-03-25
AU2772292A (en) 1993-04-27
ATE168008T1 (de) 1998-07-15
CZ69494A3 (en) 1994-07-13
PL170495B1 (en) 1996-12-31
FR2681863B1 (fr) 1995-02-03
NO941036L (no) 1994-03-22
IL103270A0 (en) 1993-02-21
PL170357B1 (en) 1996-12-31
EP0605646A1 (de) 1994-07-13
MX9205461A (es) 1993-03-01
HUT67672A (en) 1995-04-28
TW202393B (de) 1993-03-21
ZA927330B (en) 1993-04-21
FR2681863A1 (fr) 1993-04-02
IL103270A (en) 1996-11-14
WO1993005782A1 (fr) 1993-04-01
CA2119270A1 (fr) 1993-04-01
SG59982A1 (en) 1999-02-22
NZ244479A (en) 1995-04-27
EP0534860A1 (de) 1993-03-31
JPH07503941A (ja) 1995-04-27
AU671602B2 (en) 1996-09-05
YU86792A (sh) 1995-10-03
SK34894A3 (en) 1994-08-10

Similar Documents

Publication Publication Date Title
DE69226192D1 (de) Sparfloxacin-Salze und sie enthaltende Lösungen
AU563777B2 (en) Piperazine-quinoline derivatives in basic aqueous pharmaceutical preparations
DK232989D0 (da) Antiviralt praeparat
DK324185D0 (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
IL83086A0 (en) Stable,injectable solutions of vinca dimer salts
DK408083A (da) Isoquinolinderivater, deres fremstilling og anvendelse
FI902900A0 (fi) Menetelmä kiteisten kefeemihappoadditiosuolojen valmistamiseksi
YU47723B (sh) Postupak za dobivanje derivata 2-imino-3-heterocikloalkilbenzotiazolina
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning
DE59010385D1 (de) Polare Cephalosporinderivate und Verfahren zu ihrer Herstellung
RU94019970A (ru) Водный раствор спарфлоксацина, способ его получения и соль спарфлоксацина и фармацевтическая композиция

Legal Events

Date Code Title Description
8332 No legal effect for de